Activator of G-protein signaling 8 is involved in VEGF-induced choroidal neovascularization
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Activator of G-protein signaling 8 is involved in VEGF-induced choroidal neovascularization ; volume:9 ; number:1 ; day:7 ; month:2 ; year:2019 ; pages:1-11 ; date:12.2019
Scientific reports ; 9, Heft 1 (7.2.2019), 1-11, 12.2019
- Classification
-
Naturwissenschaften
- Creator
-
Hayashi, Hisaki
Mamun, Abdullah Al
Takeyama, Masayuki
Yamamura, Aya
Zako, Masahiro
Yagasaki, Rina
Nakahara, Tsutomu
Kamei, Motohiro
Sato, Motohiko
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-38067-4
- URN
-
urn:nbn:de:101:1-2019030820413013968013
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hayashi, Hisaki
- Mamun, Abdullah Al
- Takeyama, Masayuki
- Yamamura, Aya
- Zako, Masahiro
- Yagasaki, Rina
- Nakahara, Tsutomu
- Kamei, Motohiro
- Sato, Motohiko
- SpringerLink (Online service)
Other Objects (12)
Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture
Inflammasome activation aggravates choroidal neovascularization
Efficacy of simultaneous VEGF ‐A/ANG ‐2 neutralization in suppressing spontaneous choroidal neovascularization
Development of a rat choroidal neovascularization model by overexpressing VEGF with and without treatment
A new model of choroidal neovascularization
Peripapillary choroidal neovascularization in pars planitis
Long-Term Outcomes of High-Dose Conbercept Treatment for Myopic Choroidal Neovascularization and Idiopathic Choroidal Neovascularization
Fruquintinib inhibits VEGF/VEGFR2 axis of choroidal endothelial cells and M1-type macrophages to protect against mouse laser-induced choroidal neovascularization
Spontaneous retinal pigment epithelial tear in type 2 choroidal neovascularization: repair mechanisms following anti-VEGF therapy
MiRNA-21-HIF-1α-VEGF Axis Is Associated with Myopic Choroidal Neovascularization in Guinea Pigs
Erythropoietin Signaling Increases Choroidal Macrophages and Cytokine Expression, and Exacerbates Choroidal Neovascularization
Assessment of choroidal osteoma complicating choroidal neovascularization by optical coherence tomography angiography
Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture
Inflammasome activation aggravates choroidal neovascularization
Efficacy of simultaneous VEGF ‐A/ANG ‐2 neutralization in suppressing spontaneous choroidal neovascularization
Development of a rat choroidal neovascularization model by overexpressing VEGF with and without treatment
A new model of choroidal neovascularization
Peripapillary choroidal neovascularization in pars planitis
Long-Term Outcomes of High-Dose Conbercept Treatment for Myopic Choroidal Neovascularization and Idiopathic Choroidal Neovascularization
Fruquintinib inhibits VEGF/VEGFR2 axis of choroidal endothelial cells and M1-type macrophages to protect against mouse laser-induced choroidal neovascularization
Spontaneous retinal pigment epithelial tear in type 2 choroidal neovascularization: repair mechanisms following anti-VEGF therapy
MiRNA-21-HIF-1α-VEGF Axis Is Associated with Myopic Choroidal Neovascularization in Guinea Pigs
Erythropoietin Signaling Increases Choroidal Macrophages and Cytokine Expression, and Exacerbates Choroidal Neovascularization
Assessment of choroidal osteoma complicating choroidal neovascularization by optical coherence tomography angiography
Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture
Inflammasome activation aggravates choroidal neovascularization
Efficacy of simultaneous VEGF ‐A/ANG ‐2 neutralization in suppressing spontaneous choroidal neovascularization
Development of a rat choroidal neovascularization model by overexpressing VEGF with and without treatment
A new model of choroidal neovascularization
Peripapillary choroidal neovascularization in pars planitis
Long-Term Outcomes of High-Dose Conbercept Treatment for Myopic Choroidal Neovascularization and Idiopathic Choroidal Neovascularization
Fruquintinib inhibits VEGF/VEGFR2 axis of choroidal endothelial cells and M1-type macrophages to protect against mouse laser-induced choroidal neovascularization
Spontaneous retinal pigment epithelial tear in type 2 choroidal neovascularization: repair mechanisms following anti-VEGF therapy
MiRNA-21-HIF-1α-VEGF Axis Is Associated with Myopic Choroidal Neovascularization in Guinea Pigs
Erythropoietin Signaling Increases Choroidal Macrophages and Cytokine Expression, and Exacerbates Choroidal Neovascularization